Intelligence Platform
Patents
Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10358419
1,3-dipolar [70]fulleropyrrolidinium iodide derivatives
granted patentUS 10357464
Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief
granted patentUS 10357448
Echogenic vehicle for clinical delivery of plasminogen activator and other fibrin-binding
granted patentUS 10351522
Sulfonamide derivative and pharmaceutically acceptable acid addition salt thereof
granted patentUS 10342822
Method of producing physiological and therapeutic levels of nitric oxide through an oral d
granted patentUS 10344025
GLS1 inhibitors for treating disease
granted patentUS 10342771
Creatine oral supplementation using creatine hydrochloride salt
granted patentUS 10345310
Diagnostic test for early stage cancer
granted patentUS 10335470
Immunogenic compositions comprising progastrin and uses thereof
granted patentUS 10335476
Vaccine to protect against Ehrlichia infection
granted patentUS 10336786
Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
granted patentUS 10335382
Use of hydrogen sulfide synthesis inhibitors for cancer therapy
granted patentUS 10329326
Melanocortin 1 receptor ligands and methods of use
granted patentUS 10329353
Specific detection tool for mesenchymal and epithelial-mesenchymal transformed circulating
granted patentUS 10328139
Live-attenuated vaccine against plague
granted patentUS 10330600
Plasmonic-magnetic bifunctional nanotubes for biological applications
granted patentUS 10328040
Therapeutic methods
granted patentUS 10323070
VMP-like sequences of pathogenic Borrelia species and strains
granted patentUS 10322069
Restorative resin compositions and methods of use
granted patentUS 10322113
Pharmaceutical compositions directly targeting FKBP52 for the treatment of prostate cancer
granted patentUS 10322171
Vaccine with reduced enhancement of viral infection
granted patentUS 10316050
PT (IV) complexes containing 4,4β²-disubstituted-2,2β²-bipyridyl and their use in cancer the
granted patentUS 10316073
FCRN antagonists and methods of use
granted patentUS 10314950
Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applicati
granted